Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time Business Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time newsyweb.com April 20, 2026 0 Gurugram, Haryana, India: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has announced the successful completion of a USFDA... Read More Read more about Morepen Labs’ Facility Clears USFDA Inspection with NIL Adverse Observation for the Record Fourth Consecutive Time